Correction to: RIC in COVID-19—a Clinical Trial to Investigate Whether Remote Ischemic Conditioning (RIC) Can Prevent Deterioration to Critical Care in Patients with COVID-19 : RIC in COVID-19—a Clinical Trial to Investigate Whether Remote Ischemic Conditioning (RIC) Can Prevent Deterioration to Critical Care in Patients with COVID-19 (Cardiovascular Drugs and Therapy, (2021), 10.1007/s10557-021-07221-y)
Dagsetning
Höfundar
Journal Title
Journal ISSN
Volume Title
Útgefandi
Útdráttur
The original article has been corrected. Author “Dereks M. Yellon” should be “Derek M. Yellon.”.
Lýsing
Publisher Copyright: © 2021, Springer Science+Business Media, LLC, part of Springer Nature.
Efnisorð
Erratum, COVID-19, Clinical trial, Cytokines, Immunosuppression, Remote ischemic conditioning, Pharmacology, Cardiology and Cardiovascular Medicine, Pharmacology (medical)
Citation
Davidson, S M, Lukhna, K, Gorog, D A, Salama, A D, Castillo, A R, Giesz, S, Golforoush, P, Kalkhoran, S B, Lecour, S, Imamdin, A, do Carmo, H R P, Bovi, T G, Perroud, M W, Ntsekhe, M, Sposito, A C & Yellon, D M 2021, 'Correction to: RIC in COVID-19—a Clinical Trial to Investigate Whether Remote Ischemic Conditioning (RIC) Can Prevent Deterioration to Critical Care in Patients with COVID-19 : RIC in COVID-19—a Clinical Trial to Investigate Whether Remote Ischemic Conditioning (RIC) Can Prevent Deterioration to Critical Care in Patients with COVID-19 (Cardiovascular Drugs and Therapy, (2021), 10.1007/s10557-021-07221-y)', Cardiovascular Drugs and Therapy. https://doi.org/10.1007/s10557-021-07223-w